AANS Neurosurgeon | Volume 26, Number 4, 2017


Scientists Identify Novel Genes Linked to Motor Neuron Disease

This study reveals three new risk genes for ALS, and one of these – C21orf2 – increases an individual’s risk of developing the disease by 65 percent. These results could aid the development of personalized treatments for people with ALS by using gene therapy – an approach which involves replacing faulty genes or adding new ones. One in every 400 people will be diagnosed with ALS at some point in their lives, yet its causes are largely unknown and effective treatments are therefore lacking. To read more, click here.


Winter Clinics for Cranial and Spinal Surgery
Feb. 25, 2018 - Mar. 1, 2018; Snowmass Village, Colo.

69th Southern Neurosurgical Society Annual Meeting
Feb. 28, 2018 - Mar. 3, 2018; San Juan, PR

Second International Brain Mapping Course
April 26-27, 2018; New Orleans

Comments are closed.